| 000 | 01859 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515193253.0 | ||
| 264 | 0 | _c20091221 | |
| 008 | 200912s 0 0 eng d | ||
| 022 | _a1520-4804 | ||
| 024 | 7 |
_a10.1021/jm901278z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSrinivasan, Balasubramanian | |
| 245 | 0 | 0 |
_aStructure-activity relationship studies of chalcone leading to 3-hydroxy-4,3',4',5'-tetramethoxychalcone and its analogues as potent nuclear factor kappaB inhibitors and their anticancer activities. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cNov 2009 |
||
| 300 |
_a7228-35 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemistry |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aCell Transformation, Neoplastic |
| 650 | 0 | 4 |
_aChalcone _xanalogs & derivatives |
| 650 | 0 | 4 |
_aChalcones _xchemistry |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenes, Reporter |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aI-kappa B Kinase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 |
_aInterleukin-1 Receptor-Associated Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aLuciferases _xmetabolism |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
| 700 | 1 | _aJohnson, Thomas E | |
| 700 | 1 | _aLad, Rahul | |
| 700 | 1 | _aXing, Chengguo | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 52 _gno. 22 _gp. 7228-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm901278z _zAvailable from publisher's website |
| 999 |
_c19271626 _d19271626 |
||